IPO Comments to USPTO on Proposal Regarding U.S. Practitioner Representation
IPO Comments to USPTO on Proposal Regarding U.S. Practitioner Representation
IPO Comments to USPTO Regarding Notice of Proposed Rulemaking on “Revision to Rules of Practice Before the Patent Trial and Appeal Board”
IPO Comments to USPTO Regarding Notice of Proposed Rulemaking on [...]
IPO Comments to UKIPO in Response to the Consultation on Changes to the UK Designs Framework
IPO Comments to UKIPO in Response to the Consultation on [...]
IPO Comments to OSTP on Regulatory Reform on Artificial Intelligence
IPO Comments to OSTP on Regulatory Reform on Artificial Intelligence
IPO Comments to INPI Regarding Draft Guidelines for Patent Examination of AI-Related Inventions
IPO Comments to INPI Regarding Draft Guidelines for Patent Examination [...]
IPO Comments to USTR Regarding 2025 Notorious Markets
IPO Comments to USTR Regarding 2025 Notorious Markets
IPO Comments to USPTO Regarding OECD Draft Voluntary Guidelines for Countering Illicit Trade in Counterfeit Goods on Online Marketplaces
IPO Comments to USPTO Regarding OECD Draft Voluntary Guidelines for [...]
IPO Comments to CNIPA Regarding Draft Amendment to the Patent Examination Guidelines
IPO Comments to CNIPA Regarding Draft Amendment to the Patent [...]
IPO’s Letter to the American Law Institute (ALI) Requesting Removal of Name from Copyright Restatement Project
IPO’s Letter to the American Law Institute (ALI) Requesting Removal [...]
IPO’s Comments to China’s NMPA on the “Implementation Measures for the Protection of Drug Trial Data” and the “Working Procedures for the Protection of Drug Trial Data.”
IPO’s Comments to China’s NMPA on the "Implementation Measures for [...]
Posts tagged here will show on the testimony and comments page.